Navigation Links
Gene variations explain drug dose required to control seizures

improve dosing decisions, he added. In particular, it may be clinically relevant to determine whether physicians can safely increase drug doses more rapidly for some patients. Such a trial might also allow physicians to identify patients who might safely take a smaller dose, thereby minimizing their risk for adverse side effects, he added.

The findings in epilepsy set the stage for scientists to evaluate other conditions in which gene-based diagnostics might help determine the optimum dosage of particular therapies for particular patients, Goldstein said.

"For most drugs we know a lot about how and where they act in the body," Goldstein said. "The current results support the idea that known drug targets, transporters and drug metabolizing enzymes are good starting points for understanding variation among patients in drug response."

In Parkinson's disease, for example, a pharmacogenetic test might assist physicians in prescribing the drug dose that will balance short-term control of tremors with long-term drug side effects that eventually render the disease untreatable, he said. Patients' genetic makeup might also influence the dose of chemotherapy needed to successfully fight a tumor, while minimizing often intolerable side effects.


'"/>

Source:Duke University Medical Center


Page: 1 2 3 4

Related biology news :

1. Researchers map of genetic variations implicated in disease
2. A new kind of mutation could explain numerous phenotypic variations in various species
3. Gene variations contribute to aggression and anger in women
4. Jumping gene helps explain immune systems abilities
5. Gene sequencing explains bioremediation bug
6. Variation in womens X chromosomes may explain differences among individuals, between sexes
7. Iron exporter revealed that may explain common human disorder
8. New book explains antibiotic resistance for a broad audience
9. Cats indifference towards sugar explained
10. Monkeypox mystery: New research may explain why 2003 outbreak in the US wasnt deadly
11. Scientist uses form to explain function of key building blocks of life
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Gene variations explain drug dose required control seizures

(Date:7/10/2014)... inflammatory skin diseases psoriasis* and eczema** are similar in ... base their decision on which treatment should be selected ... samples. A team of researchers at the Helmholtz Zentrum ... now analyzed the molecular processes that occur in both ... for the first time to gain a detailed understanding ...
(Date:7/9/2014)... pivotal in the development of cancer, viral infection and ... question about one of the most widely-researched proteins in ... of thousands of research papers and millions of pounds ... in Professor Sir Philip Cohen,s laboratory at the University ... is activated. The results are published today ...
(Date:7/9/2014)... LAFAYETTE, Ind. - Regulated deer hunts in Indiana state ... from decades of damage caused by overabundant populations of ... team led by Michael Jenkins, associate professor of forest ... Resources policy of organizing hunts in state parks has ... and wildflowers rendered scarce by browsing deer. , ...
Breaking Biology News(10 mins):New diagnostic test to distinguish psoriasis from eczema 2Research reveals how key controller protein is switched on 2Hunting gives deer-damaged forests in state parks a shot at recovery 2
... The American Psychological Association, the largest psychological ... "Distinguished Scientific Award for Early Career Contribution to ... Research Institute at the University of Veterinary Medicine, ... Range,s ground-breaking research on animal cognition and will ...
... the researchers to see an aspect of light that humans ... sensitive to polarized light, many reef dwelling animals are but ... studies of reef communities. Thanks to generous support provided ... team of researchers from the Ecology of Vision Laboratory in ...
... of rare, endemic species in the Central Andes remain ... climate change, according to a Duke University-led international study. ... particularly vulnerable to changes in the environment or climate. ... percent of the areas with high numbers of these ...
Cached Biology News:Dancing with wolves -- prestigious award goes to a scientist at the Vetmeduni Vienna 2Capturing an octopus-eye view of the Great Barrier Reef 280 percent of 'irreplaceable' habitats in Andes unprotected 2
(Date:1/15/2014)... 2014 Cynvenio, a cancer diagnostics company ... genomic analysis of tumor cells in the bloodstream, today ... cancer decision support application powered by CollabRx, Inc. ... genomic test, Therapy Finder will provide breast cancer patients ...
(Date:1/15/2014)... 2014 A study has been launched to ... 1 track could help to tackle the problem of obesity. ... (a GP surgery based in Stowmarket) and academics at University ... Telemetry technology, which is inspired by equipment used to ...
(Date:1/15/2014)... 2014 DTS Language Services, Inc . ... Portal for Life Science organizations who need document translations. ... matter of their documents in advance with a selection of ... of translations, often a critical factor in clinical and scientific ...
(Date:1/15/2014)... 15, 2014 TaiGen Biotechnology Company, Limited ("TaiGen") today ... R-Pharm, a leading Russian pharmaceutical company, to develop and ... Russian Federation , Turkey ... is a novel antibiotic for the treatment of bacterial ...
Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4DTS Improves Efficiency for Life Science Document Translations 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
... This release is available in German ... say, on plastic foils, have excellent potential to lower ... called "balance-of-system" cost, thus enabling affordable solar electricity in ... on polymer films have been lacking behind in performance ...
... Generex Biotechnology Corporation,s (OTCBB: GNBT) ( www.generex.com ) wholly-owned ... that its lead drug candidate AE37, a novel HER-2/neu-targeted ... of breast cancer, is featured in the October 2011 ... titled "A New Ally Against Cancer" by Eric von ...
... NEW YORK, Sept. 21, 2011 Reportlinker.com announces ... in its catalogue: Separation ... http://www.reportlinker.com/p0619255/Separation-Systems-for-Commercial-Biotechnology.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biotechnology THIS REPORT ... the U.S. market for separation systems for commercial ...
Cached Biology Technology:How to produce flexible CIGS solar cells with record efficiency 2Antigen Express' AE37 Cancer Vaccine Featured in Scientific American 2Antigen Express' AE37 Cancer Vaccine Featured in Scientific American 3Antigen Express' AE37 Cancer Vaccine Featured in Scientific American 4Separation Systems for Commercial Biotechnology 2Separation Systems for Commercial Biotechnology 3Separation Systems for Commercial Biotechnology 4Separation Systems for Commercial Biotechnology 5Separation Systems for Commercial Biotechnology 6Separation Systems for Commercial Biotechnology 7Separation Systems for Commercial Biotechnology 8Separation Systems for Commercial Biotechnology 9Separation Systems for Commercial Biotechnology 10Separation Systems for Commercial Biotechnology 11